Roque Cardona-Hernandez

Dr. Roque Cardona-Hernandez


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ILIsabel Leiva-Gea
Isabel Leiva-Gea
MYM. Yan
M. Yan
RCRoque Cardona-Hernandez
Roque Cardona-Hernandez
MLMarta Ferrer Lozano
Marta Ferrer Lozano
PBPilar Bahíllo-Curieses
Pilar Bahíllo-Curieses
JSJacobo Pérez Sánchez
Jacobo Pérez Sánchez
Objective: To assess the impact of the COVID-19 pandemic and lockdown measures on the presenting characteristics (age at diagnosis, severity, monthly distribution) of newly diagnosed type 1 diabetes in Spanish children. Research Design and Methods: An ambispective observational multicenter study was conducted in nine Spanish tertiary-level hospitals between January 2015 and March 2021. Inclusion criteria: new cases of type 1 diabetes in children (0–14 years) recording age, sex, date of diagnosis, presence of diabetic ketoacidosis (DKA) at onset, and severity of DKA. Data were compared before and during the pandemic. Results: We registered 1444 new cases of type 1 diabetes in children: 1085 in the pre-pandemic period (2015–2019) and 359 during the pandemic (2020–March 2021). There was a significant increase in the group aged ≤4 years in the pandemic period (chi-squared = 10.986, df 2, p = 0.0041). In 2020–2021, cases of DKA increased significantly by 12% (95% CI: 7.2–20.4%), with a higher percentage of moderate and severe DKA, although this increase was not significant. In 2020, there was a sharp decrease in the number of cases in March, with a progressive increase from May through November, higher than in the same months of the period 2015–2019, highlighting the increase in the number of cases in June, September, and November. The first three months of 2021 showed a different trend to that observed both in the years 2015–2019 and in 2020, with a marked increase in the number of cases. Conclusions: A change in monthly distribution was described, with an increase in DKA at onset of type 1 diabetes. No differences were found in severity, although there were differences in the age distribution, with an increase in the number of cases in children under 4 years of age.

18 October 2025 in Endocrinología, Diabetes y Nutrición (English Ed.)
Verified
Journal Article
Closed access
MMMaría Asunción Martínez-Brocca
María Asunción Martínez-Brocca
VBVirginia Bellido
Virginia Bellido
RCRoque Cardona-Hernandez
Roque Cardona-Hernandez
LCLuis Castaño
Luis Castaño
ICIgnacio Conget
Ignacio Conget
DMDídac Mauricio
Dídac Mauricio

20 November 2025 in Anales de Pediatría (English Edition)
Verified
Journal Article
Open access
MMMaría Asunción Martínez-Brocca
María Asunción Martínez-Brocca
VBVirginia Bellido
Virginia Bellido
RCRoque Cardona-Hernandez
Roque Cardona-Hernandez
LCLuis Castaño
Luis Castaño
ICIgnacio Conget
Ignacio Conget
DMDídac Mauricio
Dídac Mauricio
Type 1 diabetes (T1DM) is an autoimmune disease whose late diagnosis can lead to serious complications such as diabetic ketoacidosis, especially in children. The presence of specific autoantibodies allows for the identification of a presymptomatic phase, opening the door to screening strategies targeting populations at high genetic risk, such as first-degree relatives. This document presents the consensus recommendations of the Spanish Diabetes Society (SED), the Spanish Society of Endocrinology and Nutrition (SEEN) and the Spanish Society of Paediatric Endocrinology (SEEP) on the screening, staging and monitoring of T1DM in preclinical stages. Early identification of the disease will enable a personalised approach to be established, promote health education and, eventually, consider therapeutic interventions that may delay progression to the symptomatic phase. This consensus seeks to establish a common framework for clinical action based on the available evidence, with clear recommendations for its proper implementation.